Findings primarily seen in male children with anthropometric adiposity measured at age 5 years
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — High ultraprocessed food (UPF) consumption during early childhood is associated with obesity development, primarily in males, according to a study published online Jan. 31 in JAMA Network Open.
Zheng Hao Chen, from University of Toronto, and colleagues examined the associations among UPF intake, anthropometric adiposity indicators, and obesity status in Canadian children. The analysis included 2,217 participants in the CHILD Cohort Study, with anthropometric adiposity indicators measured at 5 years of age.
The researchers found that higher UPF intake at 3 years of age was associated with higher anthropometric adiposity indicators at 5 years of age, with results primarily driven by males. For every 10 percent UPF energy increase in males, there was an association with higher adiposity indicator z scores for body mass index (β, 0.08), waist-to-height ratio (β, 0.07), and subscapular (β, 0.12) and triceps (β, 0.09) skinfold thickness. Higher odds were also observed for living with overweight or obesity (odds ratio, 1.19). Among females, there were no significant associations.
“These findings can inform public health messages directed to educate caregivers on the long-term health impact of UPF in relation to the prevention of obesity and obesity-related comorbidities,” the authors write.
Calorie Restriction and Mediterranean-Style Diet Yield Similar Weight Loss
Strength Training May Cut GDM Risk in Pregnant Women With Overweight, Obesity
Most Metabolic and Bariatric Surgery Candidates Meet Criteria for Clinical Obesity
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk